Ketogenesis: Understanding The Process And Its Timeline

Ketogenesis is the process by which the body produces ketone bodies, which provide an alternative form of energy. It occurs when the body doesn't have enough carbohydrates to burn for energy, so it burns fat and makes ketones, which can be used as fuel. This metabolic state is called ketosis. Ketogenesis occurs primarily in the mitochondria of liver cells, and the process is regulated by insulin. In healthy individuals, ketogenesis happens constantly, but at a low level. However, when there is a lack of insulin, or during fasting, sleep, or caloric restriction, ketogenesis is upregulated and the body produces more ketone bodies.

Ketogenesis and ketosis

Ketogenesis is a metabolic pathway that produces ketone bodies, which provide an alternative form of energy for the body. The body is constantly producing small amounts of ketone bodies, which can be used to make 22 ATP each in normal circumstances. The process is regulated mainly by insulin.

In a state of ketosis, ketone body production is increased when there are decreased carbohydrates or increased fatty acids. Ketosis is a metabolic state characterised by elevated levels of ketone bodies in the blood or urine. It is a normal response to low glucose availability. In physiological ketosis, ketones in the blood are elevated above baseline levels, but the body's acid-base homeostasis is maintained.

Ketogenesis produces acetone, acetoacetate, and beta-hydroxybutyrate molecules by breaking down fatty acids. These ketones are water-soluble lipid molecules made up of two R-groups attached to a carbonyl group. Of these, acetoacetate and beta-hydroxybutyrate are acidic. In healthy humans, the body is continually making a small number of ketones to be used by the body for energy. In times of fasting, even overnight while sleeping, the level of ketone bodies in the blood increases.

When carbohydrate stores are significantly decreased or fatty acid concentration increases, there is an upregulation of the ketogenic pathway and an increased production of ketone bodies. This can be seen in conditions such as type 1 diabetes, alcoholism, and starvation. Most organs and tissues can use ketone bodies as an alternative source of energy. The brain uses them as a major source of energy during periods where glucose is not readily available. The heart typically uses fatty acids as its source of energy but can also use ketones. The liver, which is the primary site of ketone body production, does not use ketone bodies because it lacks the necessary enzyme beta ketoacyl-CoA transferase.

Ketone bodies

The three main ketone bodies are acetoacetate, beta-hydroxybutyrate, and acetone. Acetoacetate and beta-hydroxybutyrate are the two ketone bodies used by the body for energy. Once they reach extrahepatic tissues, they are converted into acetyl-CoA and produce energy through the citric acid cycle. Acetone, a breakdown product of acetoacetate, is absorbed by the liver in low concentrations and undergoes detoxification. In high concentrations, acetone is absorbed by cells outside the liver and metabolized through a different pathway.

The presence of ketone bodies in the blood or urine indicates that the body is burning fats instead of glucose for energy. This is a normal and safe process, and ketone bodies serve as a backup energy source when glucose levels are low. However, excessively high levels of ketone bodies can lead to a dangerous condition called ketoacidosis, which is life-threatening and requires immediate medical attention.

Ketogenic diets

One of the key benefits of ketosis is its potential to reduce seizures in children with epilepsy by altering the "excitability" of their brains. Additionally, ketogenic diets may help improve neurological conditions such as Alzheimer's disease, autism, and brain cancers like glioblastoma. For individuals with type 2 diabetes, a keto diet can aid in weight loss and blood sugar management. Furthermore, the keto diet may lower the risk of developing cardiovascular disease by improving HDL ("good") cholesterol levels and reducing triglycerides and blood pressure.

It typically takes 2-4 days of consuming fewer than 50 grams of carbohydrates per day to enter ketosis. However, this timeframe can vary depending on factors such as physical activity level, age, metabolism, and the intake of carbohydrates, fat, and protein. Some individuals may take a week or longer to reach this state, especially if they are transitioning from a high-carb diet.

While ketogenic diets offer potential health benefits, they also come with certain drawbacks and risks. One concern is the unknown long-term health implications of the keto diet. Long-term side effects may include fat buildup in the liver, kidney stones, inadequate protein levels, and vitamin deficiencies. Additionally, the strict limits of the keto diet can make it challenging and unsustainable for many individuals. Furthermore, those with diabetes who are taking insulin or oral hypoglycemic agents must carefully adjust their medication before initiating this diet to avoid severe hypoglycemia.

Before starting a ketogenic diet, it is essential to consult with a healthcare provider to ensure it is a safe and suitable option for your specific circumstances.

Ketone body production

Ketone bodies are mainly produced in the mitochondria of liver cells. The liver produces a small amount of ketones on its own, but when glucose levels decrease, the body starts breaking down fat, which results in the production of ketones. The ketones, or ketone bodies, then become the main source of energy for the body and brain.

The three ketone bodies that are synthesized from acetyl-CoA molecules are acetoacetate, acetone, and beta-hydroxybutyrate. Acetoacetate is the most abundant, followed by acetone and then beta-hydroxybutyrate. These ketone bodies can pass through membranes easily and are, therefore, a source of energy for the brain, which cannot directly metabolize fatty acids. The brain receives 60-70% of its required energy from ketone bodies when blood glucose levels are low.

The time it takes to enter ketosis, or the metabolic state associated with the body using ketone bodies for fuel, varies from person to person. In general, it can take 2-4 days if you eat 20-50 grams of carbohydrates per day. However, some people may find it takes a week or longer to reach this state, depending on factors such as physical activity level, age, metabolism, and carbohydrate, fat, and protein intake.

Ketogenesis regulation

Ketogenesis is a metabolic pathway that produces ketone bodies, which provide an alternative form of energy for the body. It is regulated mainly by insulin and occurs primarily in the mitochondria of liver cells. In a state of ketosis, ketone body production is increased when there are decreased carbohydrates or increased fatty acids. However, ketoacidosis can occur if too many ketone bodies accumulate, such as in cases of uncontrolled diabetes.

Hormonal Regulation

The general principle of hormonal regulation states that anabolic hormones inhibit, and catabolic hormones stimulate ketogenesis. Insulin, the main anabolic hormone, strongly inhibits ketogenesis even when catabolic hormones are also secreted. Insulin blocks lipolysis in adipocytes and promotes glucose uptake and oxidation by tissues, resulting in elevated succinyl-CoA and malonyl-CoA levels. These intermediates strongly inhibit fatty acid oxidation and ketone body formation in the liver and other ketogenic tissues. When insulin levels are low, catabolic hormones such as glucagon, cortisol, growth hormone, catecholamines, epinephrine, norepinephrine, and thyroid hormones become prominent. They stimulate lipolysis and the release of free fatty acids, as well as fatty acid transport to the liver and skeletal muscles.

Transcriptional Regulation

Peroxisome Proliferator-Activated Receptor alpha (PPARα) is the chief transcription factor responsible for the induction of the majority of the genes necessary for fatty acid transport, uptake, and oxidation, as well as ketone body biosynthesis and import. PPARα is a nuclear receptor whose endogenous ligands are fatty acids and their derivatives. Transcriptional activation of PPARα target genes occurs when the heterodimeric complex of ligand-bound PPARα and retinoic X receptor (RXR) associates with peroxisome proliferator response elements (PPRE) in the gene promoters. PPARα knockout mice rapidly became hypoglycemic after food deprivation and failed to activate hepatic fatty acid oxidation and ketogenesis during fasting.

Post-translational Modifications

Palmitoylation of HMGCS2, a ketogenic enzyme, is a post-translational modification that influences the interaction with other proteins and subsequent regulation of transcription. This modification occurs spontaneously in a palmitoyl-CoA concentration-dependent manner and does not require transferase activity. Acylation on specific Cys residues of the acyl-chains is necessary for maintaining the physical interaction with PPARα protein and subsequent transactivation.

Biochemical Regulation

The rate of ketogenesis depends on the velocity of HMG-CoA synthesis by HMGCS2. This reaction is performed in three steps: the cleavage of acetyl-CoA with the formation of a covalent bond between the acetyl moiety and the thiol group of the catalytic cysteine, the binding of acetoacetyl-CoA with acetyl-SH-Enzyme and the formation of HMG-CoA, and the hydrolysis of the HMG-CoA-Enzyme intermediate with the release of HMG-CoA and free Enzyme-SH. This complex catalysis is classified as a bi-bi ping-pong mechanism, where the overall reaction rate depends on the concentrations of each substrate.

Ketogenesis also depends on the acetyl-CoA pool coming from fatty acid β-oxidation. Oxidation of long-chain fatty acids in mitochondria is controlled at the level of their transport by acylcarnitine transferase A and B. Only fatty acids of eight or fewer carbon atoms can freely enter mitochondria, while long-chain fatty acids require carnitine-mediated transport. Carnitine palmitoyltransferase 1A activity is crucial for the supply of fatty acids, and this enzyme is reversibly blocked by malonyl-CoA, a fatty acid synthesis intermediate. Therefore, in the fed state, when insulin-stimulated lipogenesis is occurring in the hepatocyte cytoplasm, fatty acid transport and their subsequent catabolism to ketone bodies in mitochondria is blocked.

Frequently asked questions